0001209191-19-021457.txt : 20190327 0001209191-19-021457.hdr.sgml : 20190327 20190327173413 ACCESSION NUMBER: 0001209191-19-021457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190327 DATE AS OF CHANGE: 20190327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stephenson Pamela CENTRAL INDEX KEY: 0001767650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 19709252 MAIL ADDRESS: STREET 1: C/O ZYNERBA PHARMACEUTICALS, INC. STREET 2: 80 W. LANCASTER AVENUE, SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-25 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001767650 Stephenson Pamela C/O ALBIREO PHARMA, INC. 10 POST OFFICE SQUARE, SUITE 502 SOUTH BOSTON MA 02109 0 1 0 0 Chief Commercial Officer Common Stock 2019-03-25 4 A 0 25000 0.00 A 25000 D Stock Option (right to buy) 28.76 2019-03-25 4 A 0 37500 0.00 A 2029-03-24 Common Stock 37500 37500 D Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on March 25, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on June 25, 2020 and ending on March 25, 2023. This option vests as to 25% of the shares on March 25, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on June 25, 2020 and ending on March 25, 2023. /s/ Jason Duncan, Attorney-in-fact 2019-03-27